We are live on !
Find out more
HighTower Trust Portfolio holdings
AUM
$1.02B
Turnover
9.48%
1-Year Est. Return
4.1%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
-4.1%
3 Year Est. Return
+90.4%
5 Year Est. Return
+71.71%
10 Year Est. Return
+89.3%
AUM
$1.02B
AUM Growth
-$13.4M
(-1.3%)
Cap. Flow
+$273K
Cap. Flow % of AUM
Cap. Flow %
0.03%
Top 10 Holdings %
Top 10 Hldgs %
54.26%
Holding
232
New
11
Increased
80
Reduced
68
Closed
11
Avg Time Held
1.8
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$3.79M |
| 2 |
ZeroFox Holdings, Inc. Common Stock
ZFOX
|
+$2.47M |
| 3 |
Philip Morris
PM
|
+$1.83M |
| 4 |
VICI Properties
VICI
|
+$836K |
| 5 |
International Flavors & Fragrances
IFF
|
+$638K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.96M |
| 2 |
ExxonMobil
XOM
|
+$1.68M |
| 3 |
Intuit
INTU
|
+$1.45M |
| 4 |
Merck
MRK
|
+$952K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$809K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 37.06% |
| 2 | Consumer Discretionary | 13.4% |
| 3 | Technology | 11.67% |
| 4 | Financials | 8.06% |
| 5 | Consumer Staples | 7.88% |
Similar funds
BFG
IMOV
DW
KI
SG
OAMG
HighTower Trust's Q1 2023 Portfolio in Review
As of Q1 2023, HighTower Trust held 232 positions worth $1.02B, down 1.3% from $1.04B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
HighTower Trust's Q1 2023 filing shows 11 new, 80 increased, 68 reduced and 11 closed positions. Its largest new stake was ZeroFox Holdings, Inc. Common Stock: 806,852 shares worth $2.01M. The largest sale was Johnson & Johnson, an estimated $4.96M.
By sector, the portfolio is most concentrated in Energy at 37% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Technology.
- HighTower Trust's largest Q1 2023 buy was ZeroFox Holdings, Inc. Common Stock: 806,852 shares worth $2.01M.
- HighTower Trust added most to AstraZeneca in Q1 2023, an estimated $3.79M increase.
- HighTower Trust's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $4.96M.
- HighTower Trust fully exited Kimberly-Clark in Q1 2023, selling an estimated $706K.
- HighTower Trust's ten largest holdings make up 54% of its $1.02B portfolio in Q1 2023.
- HighTower Trust opened 11 new positions and closed 11 in Q1 2023.
- HighTower Trust's portfolio value fell 1.3% quarter-over-quarter to $1.02B.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.